ASIC5
gene geneOn this page
Also known as INACHINAC
Summary
ASIC5 (acid sensing ion channel subunit family member 5, HGNC:17537) is a protein-coding gene on chromosome 4q32.1, encoding Bile acid-sensitive ion channel (Q9NY37). Forms bile acid-gated sodium channels and may play a role in bile acid-dependent absorption and secretion by epithelial cells of the bile ducts.
This gene belongs to the amiloride-sensitive Na+ channel and degenerin (NaC/DEG) family, members of which have been identified in many animal species ranging from the nematode to human. The amiloride-sensitive Na(+) channel encoded by this gene is primarily expressed in the small intestine, however, its exact function is not known.
Source: NCBI Gene 51802 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 95 total — 1 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_017419
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17537 |
| Approved symbol | ASIC5 |
| Name | acid sensing ion channel subunit family member 5 |
| Location | 4q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | INAC, HINAC |
| Ensembl gene | ENSG00000256394 |
| Ensembl biotype | protein_coding |
| OMIM | 616693 |
| Entrez | 51802 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000537611
RefSeq mRNA: 1 — MANE Select: NM_017419
NM_017419
CCDS: CCDS3793
Canonical transcript exons
ENST00000537611 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000740201 | 155831824 | 155831915 |
| ENSE00000856060 | 155829729 | 155830046 |
| ENSE00001001790 | 155866187 | 155866277 |
| ENSE00001081611 | 155836689 | 155836857 |
| ENSE00002210343 | 155838813 | 155838869 |
| ENSE00002228275 | 155854077 | 155854314 |
| ENSE00002232540 | 155842207 | 155842354 |
| ENSE00002259610 | 155843681 | 155843830 |
| ENSE00002266776 | 155852191 | 155852316 |
| ENSE00002306963 | 155863448 | 155863754 |
Expression profiles
Bgee: expression breadth broad, 17 present calls, max score 64.90.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0035 / max 1.9656, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 54541 | 0.0035 | 3 |
Top tissues by expression
224 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 64.90 | silver quality |
| duodenum | UBERON:0002114 | 60.81 | gold quality |
| jejunal mucosa | UBERON:0000399 | 58.78 | silver quality |
| jejunum | UBERON:0002115 | 50.36 | gold quality |
| upper leg skin | UBERON:0004262 | 46.41 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 42.00 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.57 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| oviduct epithelium | UBERON:0004804 | 41.32 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| mammary duct | UBERON:0001765 | 39.98 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 39.95 | gold quality |
| deltoid | UBERON:0001476 | 39.83 | gold quality |
| saphenous vein | UBERON:0007318 | 39.83 | gold quality |
| parotid gland | UBERON:0001831 | 39.81 | gold quality |
| oocyte | CL:0000023 | 39.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.64 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting ASIC5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-10523-5P | 99.91 | 69.22 | 2038 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-548O-3P | 99.74 | 69.30 | 2228 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-520E-5P | 99.27 | 68.90 | 1513 |
| HSA-MIR-2681-3P | 98.18 | 65.28 | 577 |
| HSA-MIR-96-3P | 97.47 | 68.03 | 839 |
| HSA-MIR-625-3P | 97.32 | 66.55 | 554 |
Literature-anchored findings (GeneRIF, showing 1)
- hBASIC shares further key features with its rat ortholog: it is blocked by extracellular divalent cations, is inhibited by micromolar concentrations of the diarylamidine diminazene, and activated by millimolar concentrations of flufenamic acid. (PMID:23842738)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Asic5 | ENSMUSG00000028008 |
| rattus_norvegicus | Asic5 | ENSRNOG00000011842 |
| drosophila_melanogaster | ppk | FBGN0020258 |
| drosophila_melanogaster | rpk | FBGN0022981 |
| drosophila_melanogaster | ppk26 | FBGN0035785 |
| caenorhabditis_elegans | WBGENE00020897 |
Paralogs (8): ASIC4 (ENSG00000072182), ASIC2 (ENSG00000108684), ASIC1 (ENSG00000110881), SCNN1A (ENSG00000111319), SCNN1D (ENSG00000162572), SCNN1G (ENSG00000166828), SCNN1B (ENSG00000168447), ASIC3 (ENSG00000213199)
Protein
Protein identifiers
Bile acid-sensitive ion channel — Q9NY37 (reviewed: Q9NY37)
Alternative names: Acid-sensing ion channel subunit family member 5, Amiloride-sensitive cation channel 5, intestinal, Human intestine Na(+) channel
All UniProt accessions (1): Q9NY37
UniProt curated annotations — full annotation on UniProt →
Function. Forms bile acid-gated sodium channels and may play a role in bile acid-dependent absorption and secretion by epithelial cells of the bile ducts. Displays high selectivity for sodium ions but can also permit the permeation of other cations. The gating could be indirect and the consequence of alterations of the membrane environment of the channel by bile acids. As a sodium channel of type II unipolar brush cells of the vestibulocerebellum, controlling the electrical activity of these cells, could play a role in motor coordination and balance.
Subunit / interactions. Forms homotrimeric channels.
Subcellular location. Apical cell membrane. Cell membrane.
Tissue specificity. Detected in small intestine, duodenum and jejunum. Detected at very low levels in testis and rectum.
Activity regulation. Inhibited by the diuretic drug amiloride.
Similarity. Belongs to the amiloride-sensitive sodium channel (TC 1.A.6) family. ASIC5 subfamily.
RefSeq proteins (1): NP_059115* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001873 | ENaC | Family |
Pfam: PF00858
Catalyzed reactions (Rhea), 4 shown:
- K(+)(in) = K(+)(out) (RHEA:29463)
- Na(+)(in) = Na(+)(out) (RHEA:34963)
- H(+)(in) = H(+)(out) (RHEA:34979)
- Li(+)(in) = Li(+)(out) (RHEA:78551)
UniProt features (24 total): glycosylation site 8, disulfide bond 6, topological domain 3, transmembrane region 2, mutagenesis site 2, chain 1, region of interest 1, short sequence motif 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9MKY | ELECTRON MICROSCOPY | 3 |
| 9MLV | ELECTRON MICROSCOPY | 3.4 |
| 9MKZ | ELECTRON MICROSCOPY | 3.47 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NY37-F1 | 84.59 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (6): 112–207, 185–192, 298–377, 315–373, 328–350, 330–342
Glycosylation sites (8): 178, 179, 306, 370, 405, 421, 147, 163
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 443 | slightly activates the channel. |
| 443 | activates the channel. |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-2672351 | Stimuli-sensing channels |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-983712 | Ion channel transport |
MSigDB gene sets: 74 (showing top):
chr4q32, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, CATRRAGC_UNKNOWN, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4, GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOCC_APICAL_PLASMA_MEMBRANE, GOBP_IMPORT_INTO_CELL, GOBP_NEURONAL_ACTION_POTENTIAL, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, AP4_01, GOCC_APICAL_PART_OF_CELL, GOBP_REGULATION_OF_MEMBRANE_POTENTIAL, GOCC_PLASMA_MEMBRANE_REGION
GO Biological Process (7): neuronal action potential (GO:0019228), sodium ion transmembrane transport (GO:0035725), sodium ion import across plasma membrane (GO:0098719), monoatomic ion transport (GO:0006811), sodium ion transport (GO:0006814), monoatomic ion transmembrane transport (GO:0034220), proton transmembrane transport (GO:1902600)
GO Molecular Function (4): proton channel activity (GO:0015252), ligand-gated sodium channel activity (GO:0015280), bile acid-gated sodium channel activity (GO:0160228), sodium channel activity (GO:0005272)
GO Cellular Component (3): plasma membrane (GO:0005886), apical plasma membrane (GO:0016324), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Ion channel transport | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| monoatomic cation transmembrane transport | 2 |
| monoatomic cation channel activity | 2 |
| sodium channel activity | 2 |
| action potential | 1 |
| transmission of nerve impulse | 1 |
| sodium ion transport | 1 |
| sodium ion transmembrane transport | 1 |
| inorganic cation import across plasma membrane | 1 |
| transport | 1 |
| metal ion transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| proton transmembrane transporter activity | 1 |
| ligand-gated monoatomic cation channel activity | 1 |
| sodium ion transmembrane transporter activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| apical part of cell | 1 |
| plasma membrane region | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
350 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ASIC5 | TAS2R60 | P59551 | 368 |
| ASIC5 | GAK | O14976 | 350 |
| ASIC5 | TAS2R42 | Q7RTR8 | 349 |
| ASIC5 | GPR22 | Q99680 | 348 |
| ASIC5 | SPMIP5 | Q8WW14 | 341 |
| ASIC5 | GPR142 | Q7Z601 | 332 |
| ASIC5 | GPR171 | O14626 | 318 |
| ASIC5 | ATOSA | Q32MH5 | 313 |
| ASIC5 | GLT1D1 | Q96MS3 | 307 |
| ASIC5 | KCNK5 | O95279 | 307 |
| ASIC5 | GPR174 | Q9BXC1 | 307 |
| ASIC5 | TAS2R41 | P59536 | 301 |
| ASIC5 | TAS2R1 | Q9NYW7 | 296 |
| ASIC5 | LCN9 | Q8WX39 | 291 |
| ASIC5 | SDR42E1 | Q8WUS8 | 288 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ASIC5 | BLVRA | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (8): BLVRA (Affinity Capture-MS), FBXO2 (Affinity Capture-MS), VPS13B (Affinity Capture-MS), USP33 (Affinity Capture-MS), CSGALNACT2 (Affinity Capture-MS), SHCBP1 (Affinity Capture-MS), TUBB7P (Affinity Capture-MS), ASIC5 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0ZSE6, A0ZT23, A4KX75, A5PLH4, A7MB71, F4IAL1, G0SDN0, O43173, P09534, P25656, P34389, P38566, P42838, P51578, P53740, P61644, P86091, Q09884, Q10351, Q17678, Q1MTQ5, Q25197, Q25410, Q2T9P5, Q3TT99, Q64663, Q64689, Q66KL4, Q6DE06, Q6ZXC8, Q7RTY8, Q86XS5, Q8BIK6, Q8IA41, Q8IA44, Q91VE2, Q94316, Q95JK4, Q96WW4, Q99572
Diamond homologs: O35240, P55926, P78348, Q10025, Q16515, Q1XA76, Q62962, Q6NXK8, Q6X1Y6, Q708S3, Q708S4, Q708S5, Q708S6, Q708S7, Q708S8, Q7T1N4, Q7TNS7, Q925H0, Q96FT7, Q9JHS6, Q9NY37, Q9R0W5, Q9R0Y1, Q9UHC3, Q25011, P24585, P24612, P34886, Q09274, Q17298, Q19038, O13262, P51169, Q9WU38, O13263, P37090, Q9W754, O01635
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
95 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 78 |
| Likely benign | 11 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 684614 | NM_017419.3(ASIC5):c.680G>T (p.Arg227Ile) | Pathogenic |
| 562985 | GRCh37/hg19 4q31.3-32.1(chr4:154763131-158404825)x1 | Likely pathogenic |
SpliceAI
1789 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:155852320:CAATA:C | acceptor_gain | 1.0000 |
| 4:155852324:A:C | acceptor_gain | 1.0000 |
| 4:155830044:CTG:C | acceptor_gain | 0.9900 |
| 4:155831916:C:CC | acceptor_gain | 0.9900 |
| 4:155852324:A:AC | acceptor_gain | 0.9900 |
| 4:155854267:C:CT | acceptor_gain | 0.9900 |
| 4:155863648:CCCA:C | acceptor_gain | 0.9900 |
| 4:155863649:CCA:C | acceptor_gain | 0.9900 |
| 4:155863650:C:T | acceptor_gain | 0.9900 |
| 4:155863650:CA:C | acceptor_gain | 0.9900 |
| 4:155863767:CCCA:C | acceptor_gain | 0.9900 |
| 4:155863769:C:CT | acceptor_gain | 0.9900 |
| 4:155863770:A:AC | acceptor_gain | 0.9900 |
| 4:155863770:A:C | acceptor_gain | 0.9900 |
| 4:155831912:CTCC:C | acceptor_gain | 0.9800 |
| 4:155843748:TGTGG:T | donor_gain | 0.9800 |
| 4:155854148:T:TA | donor_gain | 0.9800 |
| 4:155857947:T:C | acceptor_gain | 0.9800 |
| 4:155863651:A:C | acceptor_gain | 0.9800 |
| 4:155863764:T:TC | acceptor_gain | 0.9800 |
| 4:155866181:ACTC:A | donor_loss | 0.9800 |
| 4:155866182:CTC:C | donor_loss | 0.9800 |
| 4:155866183:TCA:T | donor_loss | 0.9800 |
| 4:155866184:CACCG:C | donor_loss | 0.9800 |
| 4:155866185:A:T | donor_loss | 0.9800 |
| 4:155866186:C:CG | donor_loss | 0.9800 |
| 4:155866186:CCGTT:C | donor_gain | 0.9800 |
| 4:155830047:C:CC | acceptor_gain | 0.9700 |
| 4:155831914:CC:C | acceptor_gain | 0.9700 |
| 4:155831915:CC:C | acceptor_gain | 0.9700 |
AlphaMissense
3367 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:155830006:A:C | S456R | 0.992 |
| 4:155830006:A:T | S456R | 0.992 |
| 4:155830008:T:G | S456R | 0.992 |
| 4:155842323:C:G | C298S | 0.989 |
| 4:155842324:A:T | C298S | 0.989 |
| 4:155836806:C:G | C373S | 0.988 |
| 4:155836807:A:T | C373S | 0.988 |
| 4:155842272:C:G | C315S | 0.988 |
| 4:155842273:A:T | C315S | 0.988 |
| 4:155838854:C:G | C342S | 0.986 |
| 4:155838855:A:T | C342S | 0.986 |
| 4:155852281:A:C | C207W | 0.985 |
| 4:155836807:A:G | C373R | 0.983 |
| 4:155863460:C:G | C112S | 0.981 |
| 4:155863461:A:T | C112S | 0.981 |
| 4:155863466:G:T | T110K | 0.981 |
| 4:155842233:C:G | C328S | 0.980 |
| 4:155842234:A:T | C328S | 0.980 |
| 4:155852282:C:G | C207S | 0.979 |
| 4:155852283:A:T | C207S | 0.979 |
| 4:155863459:A:C | C112W | 0.979 |
| 4:155863460:C:T | C112Y | 0.979 |
| 4:155830022:A:G | L451P | 0.975 |
| 4:155842324:A:G | C298R | 0.975 |
| 4:155836807:A:C | C373G | 0.974 |
| 4:155842227:C:G | C330S | 0.974 |
| 4:155842228:A:T | C330S | 0.974 |
| 4:155842273:A:G | C315R | 0.974 |
| 4:155852283:A:G | C207R | 0.974 |
| 4:155838855:A:G | C342R | 0.973 |
dbSNP variants (sampled 300 via entrez): RS10001395 (4:155845683 G>A), RS1000154524 (4:155850446 G>A), RS1000157950 (4:155858615 A>G,T), RS1000220469 (4:155857261 C>T), RS1000261173 (4:155835188 A>G), RS1000286451 (4:155835182 A>G), RS1000411735 (4:155868103 T>G), RS1000415258 (4:155852273 A>C), RS1000510487 (4:155857197 C>A,T), RS1000527078 (4:155830899 TAA>T), RS1000596740 (4:155829793 T>A), RS1000619009 (4:155836360 T>C), RS1000626648 (4:155834078 T>A,G), RS1000773742 (4:155842070 C>A,G), RS1000856021 (4:155858384 A>G)
Disease associations
OMIM: gene MIM:616693 | disease phenotypes: MIM:614391
GenCC curated gene-disease
Mondo (1): pregnancy loss, recurrent, susceptibility to, 3 (MONDO:0013729)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002932_9 | Manganese levels | 6.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| trichostatin A | affects expression, decreases reaction | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Lipopolysaccharides | increases expression, affects response to substance | 1 |
| Malathion | increases expression | 1 |
| Nickel | affects expression, decreases reaction | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pregnancy loss, recurrent, susceptibility to, 3